Vimarsana
Biggest News Aggregation in the World

Page 16 - Laboratory Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Laboratory Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Laboratory Sciences Today - Breaking & Trending Today

Altasciences Expands Laboratory Capabilities in Columbia - Vimarsana News

Altasciences Expands Laboratory Capabilities in Columbia

Altasciences' laboratory facilities in Columbia, MO, are undergoing a significant expansion, with completion expected this year. The new 8,000-square-foot space will mirror Altasciences' current bioanalytical

ARUP, University of Utah Building Lab Training Center With $3M in Federal Funds - Vimarsana News

ARUP, University of Utah Building Lab Training Center With $3M in Federal Funds

The University of Utah said it expects the new facility will allow it to meet its goal of doubling the number of annual graduates of its laboratory training program to 80.

Source: 360dx.com
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding - Vimarsana News

Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding

/PRNewswire/ -- ARUP Laboratories and the University of Utah's Division of Medical Laboratory Sciences have secured $3 million in federal funding through the...

Paxlovid has been free so far. Next year, sticker shock awaits - Vimarsana News

Paxlovid has been free so far. Next year, sticker shock awaits

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill within months, and millions of people who are at the highest risk of severe illness and are ...

Paxlovid has been free so far. Next year, sticker shock awaits. - Vimarsana News

Paxlovid has been free so far. Next year, sticker shock awaits.

The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.

Source: usf.edu